Skip to main content

NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.

Publication ,  Journal Article
Gradishar, WJ; Moran, MS; Abraham, J; Abramson, V; Aft, R; Agnese, D; Allison, KH; Anderson, B; Bailey, J; Burstein, HJ; Chen, N; Chew, H ...
Published in: J Natl Compr Canc Netw
November 2025

The treatment landscape of invasive early-stage and metastatic breast cancer is evolving constantly. These NCCN Guidelines Insights focus on recent updates included in the most recent version (version 5.2025) of the NCCN Guidelines for Breast Cancer specific to workup, locoregional therapy, surveillance, and systemic neoadjuvant/adjuvant therapy recommendations for invasive, nonmetastatic breast cancer.

Duke Scholars

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 2025

Volume

23

Issue

11

Start / End Page

426 / 436

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoadjuvant Therapy
  • Humans
  • Female
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gradishar, W. J., Moran, M. S., Abraham, J., Abramson, V., Aft, R., Agnese, D., … Kumar, R. (2025). NCCN Guidelines® Insights: Breast Cancer, Version 5.2025. J Natl Compr Canc Netw, 23(11), 426–436. https://doi.org/10.6004/jnccn.2025.0053
Gradishar, William J., Meena S. Moran, Jame Abraham, Vandana Abramson, Rebecca Aft, Doreen Agnese, Kimberly H. Allison, et al. “NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.J Natl Compr Canc Netw 23, no. 11 (November 2025): 426–36. https://doi.org/10.6004/jnccn.2025.0053.
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN Guidelines® Insights: Breast Cancer, Version 5.2025. J Natl Compr Canc Netw. 2025 Nov;23(11):426–36.
Gradishar, William J., et al. “NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.J Natl Compr Canc Netw, vol. 23, no. 11, Nov. 2025, pp. 426–36. Pubmed, doi:10.6004/jnccn.2025.0053.
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Bailey J, Burstein HJ, Chen N, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Jankowitz RC, Javid SH, Krishnamurthy J, Leitch AM, Lyons J, McCloskey S, McShane M, Mortimer J, Patel SA, Rosenberger LH, Rugo HS, Santa-Maria CA, Schneider BP, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Wei M, Wisinski KB, Yellala A, Yeung KT, Young JS, Schonfeld R, Kumar R. NCCN Guidelines® Insights: Breast Cancer, Version 5.2025. J Natl Compr Canc Netw. 2025 Nov;23(11):426–436.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

November 2025

Volume

23

Issue

11

Start / End Page

426 / 436

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoadjuvant Therapy
  • Humans
  • Female
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis